Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	IPO	Common Stock	Common Stock IPO	Additional Paid-In Capital	Additional Paid-In Capital IPO	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Balance at Dec. 31, 2022	$ 108,539		$ 3		$ 240,107		$ (1)	$ (131,570)
Balance (in shares) at Dec. 31, 2022			29,561,554
Exercise of stock options	407				407
Exercise of stock options, (in shares)			44,501
Issuance of restricted stock (in shares)			45,079
Stock-based compensation expense	3,233				3,233
Unrealized gain (loss) on investments, net	1						1
Net Income (Loss)	(29,051)							(29,051)
Balance at Mar. 31, 2023	83,129		$ 3		243,747			(160,621)
Balance (in shares) at Mar. 31, 2023			29,651,134
Balance at Dec. 31, 2022	108,539		$ 3		240,107		$ (1)	(131,570)
Balance (in shares) at Dec. 31, 2022			29,561,554
Net Income (Loss)	(82,371)
Balance at Sep. 30, 2023	199,612		$ 4		413,549			(213,941)
Balance (in shares) at Sep. 30, 2023			35,698,847
Balance at Mar. 31, 2023	83,129		$ 3		243,747			(160,621)
Balance (in shares) at Mar. 31, 2023			29,651,134
Exercise of stock options	216				216
Exercise of stock options, (in shares)			31,560
Issuance of restricted stock (in shares)			45,080
Purchases under employee stock purchase plan	612				612
Purchases under employee stock purchase plan (in shares)			152,502
Stock-based compensation expense	3,436				3,436
Issuance of common stock from public offering, net of offering costs		$ 161,803		$ 1		$ 161,802
Issuance of common stock from public offering, net of offering costs (in shares)				5,750,000
Net Income (Loss)	(24,891)							(24,891)
Balance at Jun. 30, 2023	224,305		$ 4		409,813			(185,512)
Balance (in shares) at Jun. 30, 2023			35,630,276
Exercise of stock options	138				138
Exercise of stock options, (in shares)			23,493
Issuance of restricted stock (in shares)			45,078
Stock-based compensation expense	3,598				3,598
Net Income (Loss)	(28,429)							(28,429)
Balance at Sep. 30, 2023	199,612		$ 4		413,549			(213,941)
Balance (in shares) at Sep. 30, 2023			35,698,847
Balance at Dec. 31, 2023	169,237		$ 4		418,058			(248,825)
Balance (in shares) at Dec. 31, 2023			35,866,610
Exercise of stock options	116				116
Exercise of stock options, (in shares)			22,750
Issuance of restricted stock (in shares)			44,226
Stock-based compensation expense	5,022				5,022
Net Income (Loss)	(39,061)							(39,061)
Balance at Mar. 31, 2024	135,314		$ 4		423,196			(287,886)
Balance (in shares) at Mar. 31, 2024			35,933,586
Balance at Dec. 31, 2023	$ 169,237		$ 4		418,058			(248,825)
Balance (in shares) at Dec. 31, 2023			35,866,610
Exercise of stock options, (in shares)	106,339
Unrealized gain (loss) on investments, net	$ 0
Net Income (Loss)	(109,124)
Balance at Sep. 30, 2024	75,972		$ 4		433,917			(357,949)
Balance (in shares) at Sep. 30, 2024			36,238,280
Balance at Mar. 31, 2024	135,314		$ 4		423,196			(287,886)
Balance (in shares) at Mar. 31, 2024			35,933,586
Exercise of stock options	333				333
Exercise of stock options, (in shares)			72,795
Issuance of restricted stock (in shares)			16,833
Purchases under employee stock purchase plan	737				737
Purchases under employee stock purchase plan (in shares)			161,271
Stock-based compensation expense	4,840				4,840
Net Income (Loss)	(37,276)							(37,276)
Balance at Jun. 30, 2024	103,948		$ 4		429,106			(325,162)
Balance (in shares) at Jun. 30, 2024			36,184,485
Exercise of stock options	69				69
Exercise of stock options, (in shares)			10,794
Issuance of restricted stock (in shares)			43,001
Stock-based compensation expense	4,742				4,742
Net Income (Loss)	(32,787)							(32,787)
Balance at Sep. 30, 2024	$ 75,972		$ 4		$ 433,917			$ (357,949)
Balance (in shares) at Sep. 30, 2024			36,238,280